Table 3. Literature review of TP53 variant and prognostic analysis in DLBCL.
TP53 mutation | 17p deletion/TP53 loss | Mutation with17p deletion/TP53 loss | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Treatment | Study | Year | Total cases | OS | PFS/DFS | OS | PFS/DFS | OS | PFS/DFS | |
CHOP era | Ichikawa A et al. | 1997 [23] | 102 | poor | ||||||
Stokke T et al. | 2001 [24] | 94 | poor | |||||||
Leroy K et al. | 2002 [25] | 69 | poor | |||||||
Young KH et al. | 2007 [26] | 113 | poor | NS | NS | |||||
Stöcklein H et al. | 2008 [27] | 40 | NS | NS | poor | |||||
Young KH et al. | 2008 [28] | 477 | poor | |||||||
R-CHOP era | Xu-Monette ZY et al. | 2012 [29] | 506 | poor | poor | NS | NS | |||
Asmar F et al. | 2014 [30] | 62 | poor | |||||||
Fiskvik I et al. | 2015 [31] | 43 | poor | poor | ||||||
Cao Y et al. | 2016 [14] | 165 | poor | poor | poor | poor | ||||
Zenz T et al. | 2017 [32] | 265 | poor | poor | ||||||
Present study | 2017 | 120 | 35 (Discovery cohort) | NS* | NS* | NS# | NS# | poor | poor | |
85 (Validation cohort) | NS* | NS* | NS# | NS# | poor | poor |
NS: not significant, *: TP53 mutation only, #: 17p deletion/TP53 loss only.